Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function

被引:30
|
作者
Drake, DR
Ream, RM
Lawrence, CW
Braciale, TJ
机构
[1] Univ Virginia, Hlth Syst, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA
[2] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA
[3] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA
来源
JOURNAL OF IMMUNOLOGY | 2005年 / 175卷 / 03期
关键词
D O I
10.4049/jimmunol.175.3.1507
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Engagement of the Ag receptor on naive CD8(+) T cells by specific peptide-MHC complex triggers their activation/expansion/ differentiation into effector CTL. The frequency of Ag-specific CD8(+) T cells can normally be determined by the binding of specific peptide-MHC tetramer complexes to TCR. In this study we demonstrate that, shortly after Ag activation, CD8(+) T cells transiently lose the capacity to efficiently bind peptide-MHC tetramer complexes. This transient loss of tetramer binding, which occurs in response to naturally processed viral peptide during infection in vitro and in vivo, is associated with reduced signaling through the TCR and altered/diminished effector activity. This change in tetramer binding/effector response is likewise associated with a change in cell surface TCR organization. These and related results suggest that early during CD8(+) T cell activation, there is a temporary alteration in both cell surface Ag receptor display and functional activity that is associated with a transient loss of cognate tetramer binding.
引用
收藏
页码:1507 / 1515
页数:9
相关论文
共 50 条
  • [1] Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses
    Clancy-Thompson, Eleanor
    Devlin, Christine A.
    Tyler, Paul M.
    Servos, Mariah M.
    Ali, Lestat R.
    Ventre, Katherine S.
    Bhuiyan, M. Aladdin
    Bruck, Patrick T.
    Birnbaum, Michael E.
    Dougan, Stephanie K.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (12) : 1524 - 1536
  • [2] Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming
    Gainey, Maria D.
    Rivenbark, Joshua G.
    Cho, Hyelim
    Yang, Liping
    Yokoyama, Wayne M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (47) : E3260 - E3267
  • [3] Loss of CD8 and TCR binding to class I MHC ligands following T cell activation
    Kao, C
    Daniels, MA
    Jameson, SC
    INTERNATIONAL IMMUNOLOGY, 2005, 17 (12) : 1607 - 1617
  • [4] CD8+ T cell killing of MHC class I–deficient tumors
    Christopher E. Rudd
    Nature Cancer, 2023, 4 : 1214 - 1216
  • [5] Disruption of lipid rafts decreases MHC class I tetramer binding on CD8+ T cells.
    Drake, DR
    Braciale, TJ
    FASEB JOURNAL, 2001, 15 (04): : A704 - A704
  • [6] Effects of altered glycolysis levels on CD8+ T cell activation and function
    Cao, Jiaying
    Liao, Shan
    Zeng, Feng
    Liao, Qianjin
    Luo, Gengqiu
    Zhou, Yanhong
    CELL DEATH & DISEASE, 2023, 14 (07)
  • [7] Effects of altered glycolysis levels on CD8+ T cell activation and function
    Jiaying Cao
    Shan Liao
    Feng Zeng
    Qianjin Liao
    Gengqiu Luo
    Yanhong Zhou
    Cell Death & Disease, 14
  • [8] CD8+ T cell killing of MHC class I-deficient tumors
    Rudd, Christopher E. E.
    NATURE CANCER, 2023, 4 (09) : 1214 - 1216
  • [9] T Cell Factor 1 Represses CD8+ Effector T Cell Formation and Function
    Tiemessen, Machteld M.
    Baert, Miranda R. M.
    Kok, Lianne
    van Eggermond, C. J. A.
    van den Elsen, Peter J.
    Arens, Ramon
    Staal, Frank J. T.
    JOURNAL OF IMMUNOLOGY, 2014, 193 (11): : 5480 - 5487
  • [10] Myeloid cell MHC I expression drives CD8+ T cell activation in nonalcoholic steatohepatitis
    Adams, Victoria R.
    Collins, Leonard B.
    Williams, Taufika Islam
    Holmes, Jennifer
    Hess, Paul
    Atkins, Hannah M.
    Scheidemantle, Grace
    Liu, Xiaojing
    Lodge, Mareca
    Johnson, Aaron J.
    Kennedy, Arion
    FRONTIERS IN IMMUNOLOGY, 2024, 14